Skip Navigation

This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Request Permissions
Google Scholar
Right arrow Articles by Xiong, H. Q.
Right arrow Articles by Sugimura, T.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Xiong, H. Q.
Right arrow Articles by Sugimura, T.
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Japanese Journal of Clinical Oncology 33:246-253 (2003)
© 2003 Foundation for Promotion of Cancer Research

Report of the 16th International Symposium of the Foundation for Promotion of Cancer Research: Recent Advances in Pancreatic Cancer

Henry Q. Xiong1, James L. Abbruzzese1, Hiroyasu Esumi2, Tomoo Kosuge3, Tadao Kakizoe2 and Takashi Sugimura2,+

1 University of Texas, M.D. Anderson Cancer Center, TX, USA, 2 National Cancer Center, Tokyo and 3 Hepatobiliary and Pancreatic Surgery Division, National Cancer Center Hospital, Tokyo, Japan

The first 150 words of the full text of this article appear below.


   INTRODUCTION
 
The 16th International Symposium of the Foundation for Promotion of Cancer Research, entitled ‘Recent Advances in Pancreatic Cancer’, was held in Tokyo on January 22–24, 2003. The symposium was organized by Drs Tadao Kakizoe, James L. Abbruzzese, Hiroyasu Esumi and Tomoo Kosuge. Dr Takashi Sugimura was the adviser.

The prognosis of pancreatic cancer remains dismal despite the continuous efforts of investigators. It appears as if the recent evolution of life science has left pancreatic cancer behind. However, beneath the surface, new technology and knowledge are accumulating. This symposium was intended to help them to take shape by providing outstanding researchers from Japan, Europe and the United States with an opportunity to discuss and to exchange information.


   SESSION 1: EPIDEMIOLOGY AND ETIOLOGY OF PANCREATIC CANCER
 
Chairperson: Randall E. Brand
Dr Albert B. Lowenfels reviewed the epidemiology of pancreatic cancer. He pointed out that pancreatic cancer, one of the most lethal human cancers, is now a common cause of cancer death in many countries, . . . [Full Text of this Article]


   SESSION 2: PATHOLOGY AND TUMOR BIOLOGY OF PANCREATIC CANCER
 
Chairpersons: Roland M. Schmid and Albert B. Lowenfels

   SESSION 3: DIAGNOSIS OF PANCREATIC CANCER
 
Chairpersons: Raul A. Urrutia, John P. Neoptolemos and Henry Q. Xiong

   SESSION 4: STAGING OF PANCREATIC CANCER
 
Chairperson: Chusilp Charnsangavej

   SESSION 5: SURGICAL TREATMENT OF PANCREATIC CANCER
 
Chairpersons: Philip A. Philip and Theodore S. Lawrence

   SESSION 6: NON-SURGICAL TREATMENT OF PANCREATIC CANCER
 
Chairpersons: Kevin C. Conlon and Jeffrey Lee

   ACKNOWLEDGMENTS
 

Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?